Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kadri Altundag

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
Medical Hypotheses|December 21, 2004
SRL172 (killed Mycobacterium vaccae) may augment the efficacy of trastuzumab in metastatic breast cancer patientsKadri Altundag, Ali-Seyed Mohamed, Ozden Altundag, et al.
Breast Cancer (Tokyo, Japan)|June 16, 2025
Marital status as an independent prognostic factor in male breast cancer: a SEER-based cohort studyAhmet Necati Sanli, Bilal Turan, Deniz Esin Tekcan Sanli, et al.
Annals of Plastic Surgery|December 4, 2002
Effects of growth factors on doxorubicin-induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSFIbrahim Vargel, Adnan Erdem, Dilek Ertoy, et al.
Leukemia & Lymphoma|July 7, 2007
Rituximab-related viral infections in lymphoma patientsSercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, et al.
Current Medical Research and Opinion|September 16, 2014
The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment durationMehmet A N Sendur, Sercan Aksoy, Nuriye Y Ozdemir, et al.
Medical Oncology (Northwood, London, England)|June 5, 2013
Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodesEmre Koca, Taha Y Kuzan, Omer Dizdar, et al.
Medicine|August 24, 2017
Effects of tamoxifen on urinary incontinence: Case report and review of literatureElshad Hasanov, Merve Hasanov, Issa M Kuria, et al.
Tumori|February 11, 2012
Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical responseCagatay Arslan, Sercan Aksoy, Omer Dizdar, et al.
Breast (Edinburgh, Scotland)|October 21, 2016
The association between body mass index and immunohistochemical subtypes in breast cancerSuleyman Sahin, Gokmen U Erdem, Fatih Karatas, et al.
The American Surgeon|September 12, 2012
Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?Cagatay Arslan, Metin Isik, Gulnur Guler, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
Medical Hypotheses|December 21, 2004
SRL172 (killed Mycobacterium vaccae) may augment the efficacy of trastuzumab in metastatic breast cancer patientsKadri Altundag, Ali-Seyed Mohamed, Ozden Altundag, et al.
Breast Cancer (Tokyo, Japan)|June 16, 2025
Marital status as an independent prognostic factor in male breast cancer: a SEER-based cohort studyAhmet Necati Sanli, Bilal Turan, Deniz Esin Tekcan Sanli, et al.
Annals of Plastic Surgery|December 4, 2002
Effects of growth factors on doxorubicin-induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSFIbrahim Vargel, Adnan Erdem, Dilek Ertoy, et al.
Leukemia & Lymphoma|July 7, 2007
Rituximab-related viral infections in lymphoma patientsSercan Aksoy, Hakan Harputluoglu, Saadettin Kilickap, et al.
Current Medical Research and Opinion|September 16, 2014
The efficacy of adjuvant trastuzumab in HER-2 positive breast cancer with axillary lymph node metastases according to the treatment durationMehmet A N Sendur, Sercan Aksoy, Nuriye Y Ozdemir, et al.
Medical Oncology (Northwood, London, England)|June 5, 2013
Outcomes of locally advanced breast cancer patients with ≥ 10 positive axillary lymph nodesEmre Koca, Taha Y Kuzan, Omer Dizdar, et al.
Medicine|August 24, 2017
Effects of tamoxifen on urinary incontinence: Case report and review of literatureElshad Hasanov, Merve Hasanov, Issa M Kuria, et al.
Tumori|February 11, 2012
Increased mean corpuscular volume of erythrocytes during capecitabine treatment: a simple surrogate marker for clinical responseCagatay Arslan, Sercan Aksoy, Omer Dizdar, et al.
Breast (Edinburgh, Scotland)|October 21, 2016
The association between body mass index and immunohistochemical subtypes in breast cancerSuleyman Sahin, Gokmen U Erdem, Fatih Karatas, et al.
The American Surgeon|September 12, 2012
Does androgen receptor have a prognostic role in patients with estrogen/progesterone-negative and c-erbB-2-positive breast cancer?Cagatay Arslan, Metin Isik, Gulnur Guler, et al.
Pageof 16